Business Pressures, Conflict Potential Prompt Firm to Take Sides in Drug Company IP Cases - News, Articles, and Events

Jennifer Manton
Chief Marketing Officer
212.407.4112

Business Pressures, Conflict Potential Prompt Firm to Take Sides in Drug Company IP Cases

October 26, 2010 | New York Law Journal

Loeb & Loeb LLP is profiled on the firm's strategy to move away from representing generic drug companies in order to create fewer conflicts when pitching brand-name drug companies for intellectual property work. David Schaefer is quoted on the thinking behind this strategy, spurred by today's increasingly consolidated pharmaceutical industry.

David S. Schaefer

Intellectual Property
Life Sciences Patent Litigation and Counseling
Patent Litigation and Counseling

This Web site may constitute "Attorney Advertising" under the New York Rules of Professional Conduct and under the law of other jurisdictions.
Your use of our Web site or its facilities constitutes your acceptance of the Terms of Use and Privacy Policy, which are accessible in the link at the bottom left of this page.